Ind-Swift Laboratories Ltd share price logo

Ind-Swift Laboratories Ltd

NSE: INDSWFTLAB

BSE: 532305

Small Cap

Pharma Sector

₹364.95

-13.80

(-3.64%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Ind-Swift Laboratories shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+107%

Searches for Ind-Swift Laboratories on INDmoney have increased by 107% over the last 30 days.

Investment activity on INDmoney

+59.89%

Investment activity in Ind-Swift Laboratories among INDmoney users has increased by 59.89% over the last 30 days.

Among the most traded stocks

362nd

Ind-Swift Laboratories was the 362nd most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

10 days

INDmoney investors hold Ind-Swift Laboratories shares for an average of 10 days.

Key Events for Ind-Swift Laboratories

Last Dividend Declared

₹1.00 per share, declared on 25/05/2011

View Dividend History

Ind-Swift Laboratories Stock Performance

as on September 16, 2026 at 8:57 pm IST

  • Day's Low

    Day's High

    ₹320.20
    ₹379.70
    downward going graph

    12.26%

    Downside

    4.04%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹87.15
    ₹404.00
    downward going graph

    76.12%

    Downside

    10.70%

    Upside

    downward going graph

Ind-Swift Laboratories share price movements today

Previous Close
₹378.75
Open
₹365.00
Volume
16.22L
Upper Circuit
₹454.50
Lower Circuit
₹303.00
Day's Low - High
₹320.20 - ₹379.70
52 Week Low - High
₹87.15 - ₹404.00

Ind-Swift Laboratories Historical Returns

1 Month Return
+ 21 %
3 Month Return
+ 132.88 %
1 Year Return
+ 260.51 %
3 Year Return
+ 326.04 %
5 Year Return
+ 456.17 %

Ind-Swift Laboratories Fundamentals

as on September 16, 2026 at 3:27 pm IST

Market Cap

₹3,293.67 Cr

Return on Equity (ROE)

0.64

PE Ratio (TTM)

56.5

Return on capital employed (ROCE)

1.09

Industry PE ratio

51.81

Beta (LTM)

0.78

P/B Ratio

0.53

Dividend Yield

0

PEG Ratio

-2.12

Quarterly Earnings Growth YOY

184.05

EPS (TTM)

36.44

Book Value

159.86

Ind-Swift Laboratories Stock Valuation

as on September 16, 2026 at 3:27 pm IST

Ind-Swift Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (-1795.00x)

December 8, 2022

Industry (51.81x)

September 11, 2026

Today (56.50x)

September 11, 2026

Highest (64.97x)

July 19, 2021

LowHigh

Today’s Price to Earnings Ratio: 56.50x

Ind-Swift Laboratories Technical Analysis

Track how Ind-Swift Laboratories technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish12
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
0.36
Bullish
CCI (20)
-539.85
Bullish
RSI (14)
54.9
Neutral
Momentum (10)
0.6
Bearish
ADI (14)
18.44
Neutral
Ultimate Oscillator (7,14,28)
71.38
Bullish

Moving Averages

Name

Value

Action

SMA (20)
364.4
Bullish
EMA (20)
364.6
Bullish
VWMA (20)
364.67
Bullish
SMA (50)
363.93
Bullish
EMA (50)
363.76
Bullish
SMA (200)
361.08
Bullish
EMA (200)
361.95
Bullish
KAMA (200)
363.83
Bullish
DEMA (200)
361.82
Bullish

Ind-Swift Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ind-Swift Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Ind-Swift Laboratories Ltd image
Ind-Swift Laboratories Ltd
NA3,293.6791.23%0.52250561
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Ind-Swift Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
289.71
287.51
528.57
33.17
11.96
128.8
138.24
152.73
152.64
150.85
169.79
191.45
Other Income
7.4
7.11
458.23
11.14
13.01
16.64
220.34
14.58
17.86
27.58
2.22
7.65
Total Income
297.11
294.63
986.8
44.31
24.96
145.43
358.57
167.32
170.5
178.43
172.01
199.11
Expenses
224.02
235.82
437.36
42.91
23.75
136.17
147.43
149.13
151.17
152.53
154.37
158.26
Operating Profit
65.69
51.69
91.21
-9.74
-11.79
-7.37
-9.19
3.6
1.47
-1.68
15.42
33.19
Operating Profit Margin %
22.67%
17.98%
17.26%
-29.36%
-98.58%
-5.72%
-6.65%
2.36%
0.96%
-1.11%
9.08%
17.34%
Profit Before Interest, Tax and Depreciation
73.09
58.8
549.44
1.4
1.21
9.26
211.14
18.18
19.34
25.9
17.64
40.85
Interest
21.14
21.05
2.96
0.17
0.41
10.03
-26.76
1.15
2.01
0.67
-2.43
0.71
Depreciation
13.19
13.56
19.55
0.25
0.22
5.81
7.44
6.68
6.98
8.84
8.12
7.58
Profit Before Tax
38.76
24.19
526.93
0.98
0.58
-6.58
230.46
10.35
10.35
16.39
11.95
32.56
Tax Paid
6.93
4.67
33.14
-0.03
0.18
-1.08
8.19
1.71
2.3
6.87
-3.15
7.99
Profit After Tax
31.83
19.53
493.79
1.01
0.4
-5.5
222.27
8.65
8.04
9.52
15.11
24.57
Total Net profit including share of profit / Loss from associate company
31.65
19.42
493.67
0.94
0.41
-5.49
222.27
8.78
7.99
9.54
15.12
24.68
EPS
5.36
3.29
83.55
0.16
0.07
-0.82
32.96
1.28
1
1.17
1.81
2.84
Actual EPS
5.36
3.29
83.55
0.16
0.07
-0.82
32.96
1.28
1
1.17
1.81
2.84
Adjusted EPS
5.36
3.29
83.55
0.16
0.07
-0.82
32.96
1.28
1
1.17
1.81
2.84
Diluted EPS
5.36
3.29
83.55
0.16
0.07
-0.82
30.08
1.17
0.96
1.13
1.76
2.84

Ind-Swift Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
765.48
756.6
779.64
891.34
1,038.73
1,207.31
1,709.15
561.71
641.29
Other Income
18.38
119.84
33.4
22.7
43.5
33.5
479.35
304.59
46.97
Total Income
783.86
876.44
813.04
914.04
1,082.23
1,240.81
2,188.5
866.3
688.26
Expenses
633.11
630.52
635.26
708.52
843.11
1,004.76
1,406.09
581.1
607.2
Operating Profit
132.37
126.08
144.38
182.82
195.62
202.55
303.06
-19.39
34.09
Operating Profit Margin %
17.29%
16.66%
18.52%
20.51%
18.83%
16.78%
17.73%
-3.45%
5.32%
Profit Before Interest, Tax and Depreciation
150.75
245.93
177.78
205.52
239.12
236.05
782.41
285.2
81.06
Interest
28.21
92.2
107.49
100.22
95.55
92.17
103.78
2.92
1.4
Depreciation
86.62
104.05
90.06
87.29
131.04
57.36
80.41
24.48
30.61
Profit Before Tax
35.92
49.68
-19.77
18.01
12.53
86.52
598.22
257.8
49.05
Tax Paid
14.02
20.73
1.42
21.16
14.68
38.69
58.98
7.27
7.73
Profit After Tax
21.92
28.95
-21.19
-3.15
-2.15
47.83
539.24
250.53
41.32
Total Net profit including share of profit / Loss from associate company
21.92
28.95
-21.19
-3.15
-2.15
47.6
538.75
250.48
41.42
EPS
4.86
-6.19
-4.28
-0.53
-0.36
8.06
91.18
37.25
4.95
Actual EPS
4.86
-6.19
-4.28
-0.53
-0.36
8.06
91.18
37.25
4.95
Adjusted EPS
4.86
-6.19
-4.28
-0.53
-0.36
8.06
91.18
37.25
4.95
Diluted EPS
4.86
5.96
-4.28
-0.53
-0.36
8.06
91.18
35.21
4.84

Ind-Swift Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
79.43
95.57
73.09
-64.4
125.24
134.95
150.27
194.62
-163.12
-25.47
Cash Flow from Investing Activities
-28.77
-30.94
-17.4
-12.47
-9.1
-10.18
4.78
-13.37
-104.32
-110.2
Cash Flow from Financing Activities
-47.92
-68.9
-61.98
99.62
-133.26
-123.74
-140.88
-185.66
698.91
69.2
Net Cash Flow
2.74
-4.27
-6.3
22.76
-17.12
1.03
14.17
-4.41
431.48
-66.47

Ind-Swift Laboratories Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Jul 2025
Aug 2025
Sep 2025
Dec 2025
Feb 2026
Mar 2026
Jun 2026
Promoters
42%
42%
42%
42%
42%
42%
40.94%
40.94%
36.77%
39.5%
39.5%
39.5%
43.06%
42.99%
42.93%
DII
0%
8.03%
0.94%
0.94%
0.94%
0.94%
0.91%
0.91%
0%
0%
0.68%
0.68%
0.16%
0%
0.17%
FII
0%
0.25%
1.26%
0.85%
0.65%
0.46%
3.07%
4.27%
0%
0%
14.8%
14.33%
13.8%
13.88%
10.7%
Public
38.95%
49.72%
55.8%
56.21%
56.41%
56.6%
55.07%
53.87%
45.47%
44.92%
45.02%
45.5%
42.98%
43.12%
46.2%
Total Outstanding Shares
5,90,86,860
5,90,86,860
5,90,86,860
5,90,86,860
5,90,86,860
5,90,86,860
6,06,18,860
6,06,18,860
7,23,86,860
8,16,11,558
8,16,11,558
8,16,11,558
8,67,11,558
8,68,36,558
8,69,61,558
Total Shareholders
24,633
22,439
25,461
29,536
28,883
28,752
28,117
28,709
28,907
43,984
43,780
42,121
40,404
39,222
40,881

Ind-Swift Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Ind-Swift Laboratories.

  • Ind-Swift Laboratories Ltd Earnings Results

    Ind-Swift Laboratories Ltd’s net profit jumped 181.41% since last year same period to ₹24.68Cr in the Q1 2026-2027. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated 63.34% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Ind-Swift Laboratories Ltd Dividends May,2011

    In the quarter ending March 2011, Ind-Swift Laboratories Ltd has declared dividend of ₹1.00 per share on 25 May 2011 - translating a dividend yield of 0.52%.

    Read More about Dividends

Insights on Ind-Swift Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 43.12% to 46.20% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, INDSWFTLAB stock has moved up by 132.9%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 172.01 Cr → 199.11 Cr (in ₹), with an average increase of 13.6% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, INDSWFTLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, INDSWFTLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 7.99 Cr → 24.68 Cr (in ₹), with an average increase of 30.6% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 42.99% to 42.93% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 13.88% to 10.70% in Jun 2026 quarter

About Ind-Swift Laboratories Ltd

IndSwift Laboratories Ltd is an Indian based company that manufactures and sell Active Pharmaceutical Ingredients (API). Established in 1995, the company has grown to encompass 25 products, the most significant being Clarithromycin Macrolide antibiotic, Atorvastatin anticholestrol, Fexofenadine antihistamine, Clopidogrel anticholestrol, Nitazoxanide antidiarrheal, Pioglitazone antidiabetic, Letrozole and Anastrozole anticancer, Venlafaxine antidepressants, and Quetipine and Aripirazole antipsychotic. IndSwift Laboratories Ltd has built a strong presence in 40 plus countries, have a subsidiary in the USA, and set up a state of the art R&D Centre with a USD 5 million investment. Additionally, the production capacity has been increased to 418.18 TPA and its product portfolio continues to expand with compounds like Dutasteride, Cinacalcet, Duloxetine, Mecloxamine citrate, Atomoxetine, Exemestane, and more. In order to explore new opportunities in pharma, the company has entered joint ventures with Wellgen Medicare LLP and Mr. Anshul Jain, and Mr. Ramesh Mehta. As of now, the company has 3 subsidiaries - IndSwift Laboratories Inc in the US, Fortune India Constructions Limited in India, and Halcyon Life Sciences Pvt Ltd in India.

Revenue: ₹191.45Cr as on June 2026 (Q1 FY27)
Net Profit: ₹24.57Cr as on June 2026 (Q1 FY27)
Listing date: 02 Jul, 1997
Chairperson Name: N R Munjal
OrganisationInd-Swift Laboratories Ltd
HeadquartersChandigarh
IndustryPharmaceuticals
CEON R Munjal
E-voting on sharesClick here to vote

FAQs

What is Ind-Swift Laboratories share price today?

Ind-Swift Laboratories share price today stands at ₹364.95 as on . Ind-Swift Laboratories share today touched a day high of ₹379.7 and a low of ₹320.2.

What is the 52 week high and 52 week low range for Ind-Swift Laboratories share?

Ind-Swift Laboratories touched a 52 week high of ₹404 and a 52 week low of ₹87.15. Ind-Swift Laboratories share price today i.e. is trending at ₹364.95, which is -9.67% down from its 52 week high and 318.76% up from its 52 week low.

What is Ind-Swift Laboratories's market capitalisation today?

Ind-Swift Laboratories market capitalisation is ₹3,293.67 Cr as on .

How to buy Ind-Swift Laboratories shares?

To buy Ind-Swift Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for INDSWFTLAB or Ind-Swift Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Ind-Swift Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Ind-Swift Laboratories trading volume today?

Ind-Swift Laboratories trading volume is 16.22L as on . This means that 16.22L shares of Ind-Swift Laboratories were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Ind-Swift Laboratories shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Ind-Swift Laboratories have both increased over the past 30 days, and the average INDmoney investor holds the stock for 10 days. This reflects platform activity only and is not investment advice.